New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareHexarelin vs Adamax

Hexarelin vs Adamax

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone Peptides
Hexarelin
Cognitive Enhancement
Adamax
Summary
Hexarelin is a potent synthetic GHRP and the strongest GH secretagogue in its class per unit dose. It also exhibits unique cardioprotective properties through direct binding to cardiac CD36 receptors, independent of GH release. Its potency is balanced by a tendency to desensitize GH release with prolonged use, making cycling important.
Adamax is a synthetic neuropeptide related to brain-derived neurotrophic factor (BDNF) signaling pathways. It is explored for cognitive enhancement, neuroprotection, and mood support, with proposed mechanisms involving TrkB receptor activation and enhancement of neuroplasticity similar to endogenous BDNF.
Half-Life
~70 minutes
Estimated 1-3 hours (short; peptide degradation)
Admin Route
SubQ
Subcutaneous, Intranasal (research)
Research
Typical Dose
100–200 mcg
200-400 mcg per dose
Frequency
2–3 times daily
Once daily or every other day
Key Benefits
  • Strongest GH pulse per mcg among GHRPs
  • Unique direct cardioprotective effects via CD36
  • Increased IGF-1 and muscle anabolism
  • Accelerated recovery from training
  • Bone density support
  • Anti-aging via GH axis
  • Potential cardiac rehabilitation benefits
  • Proposed enhancement of learning and memory consolidation
  • Neuroprotective via BDNF-TrkB pathway support
  • May improve mood and resilience to stress
  • Potential support for neurogenesis
  • Cognitive clarity and focus enhancement (reported anecdotally)
  • Explored for neurodegeneration and age-related cognitive decline
Side Effects
  • Water retention
  • Elevated cortisol
  • Elevated prolactin (more pronounced than other GHRPs)
  • Receptor desensitization with continuous use
  • +1 more
  • Limited human safety data; largely anecdotal reports
  • Possible headache or mild overstimulation
  • Sleep disruption with late-day dosing
  • Unknown long-term safety profile
Stacks With